|
|
|
Volumn 26, Issue 3 SUPPL. 8, 1999, Pages 33-38
|
|
Phase III randomized trials of docetaxel in patients with metastatic breast cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKYLATING AGENT;
ANTHRACYCLINE ANTIBIOTIC AGENT;
DEXAMETHASONE;
DOCETAXEL;
DOXORUBICIN;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
MITOMYCIN C;
STEROID;
VINBLASTINE;
ARTICLE;
BREAST CARCINOMA;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CARDIOTOXICITY;
CLINICAL TRIAL;
DRUG EFFICACY;
FEBRILE NEUTROPENIA;
FLUID RETENTION;
GASTROINTESTINAL SYMPTOM;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
METASTASIS;
METASTASIS INHIBITION;
NAUSEA;
NEUROTOXICITY;
ORAL DRUG ADMINISTRATION;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
SIDE EFFECT;
STOMATITIS;
TREATMENT FAILURE;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CLINICAL TRIALS, PHASE III;
HUMANS;
MITOMYCIN;
NEOPLASM METASTASIS;
PACLITAXEL;
RANDOMIZED CONTROLLED TRIALS;
SALVAGE THERAPY;
TAXOIDS;
VINBLASTINE;
|
|
EID: 0033014813
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (12)
|
|
References (35)
|
